GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
Background Despite the strong evidence concerning carcinogenic roles of glucagon-like peptide 1 receptor (GLP1R), the role of this gene in endometrial cancer (EC) remains elusive. This study investigated the properties of GLP1R on EC in vitro.Methods The expression of GLP1R in EC was detected by RT-...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Obstetrics and Gynaecology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/01443615.2023.2301324 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841553133680984064 |
---|---|
author | Wu Li Wen Lyu Songjun Liu Fan Ruan Xinmei Zhang |
author_facet | Wu Li Wen Lyu Songjun Liu Fan Ruan Xinmei Zhang |
author_sort | Wu Li |
collection | DOAJ |
description | Background Despite the strong evidence concerning carcinogenic roles of glucagon-like peptide 1 receptor (GLP1R), the role of this gene in endometrial cancer (EC) remains elusive. This study investigated the properties of GLP1R on EC in vitro.Methods The expression of GLP1R in EC was detected by RT-qPCR, immunohistochemistry, and western blotting. Cell viability, cell cycle, apoptosis, migration, invasion and ferroptosis were assessed through CCK-8, flow cytometry, wound healing, transwell, DCFH-DA and western blotting, respectively.Results We found that GLP1R was up-regulated in EC than normal specimens. It had the highest expression in AN3CA cells. Cell viability, migration and invasion were significantly reduced, while cell cycle arrest and apoptosis were induced following GLP1R knockdown. The malignant biological behaviours of AN3CA cells were investigated when treated with exendin-4 (GLP1R agonist). Moreover, GLP1R lowered intracellular ROS level and expression of SLC7A11, and FTH1, but mitigated GPX4 expression in AN3CA cells.Conclusion In a word, GLP1R was up-regulated in EC and its up-regulation facilitated the proliferative and metastatic potentials, and protected cells from ferroptosis, thereby accelerating EC progression. These data emphasised the potency of GLP1R as a therapeutic agent against EC. |
format | Article |
id | doaj-art-23dc6a07eb404f29b19f4aeb780f7ad3 |
institution | Kabale University |
issn | 0144-3615 1364-6893 |
language | English |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of Obstetrics and Gynaecology |
spelling | doaj-art-23dc6a07eb404f29b19f4aeb780f7ad32025-01-09T12:13:17ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932024-12-0144110.1080/01443615.2023.2301324GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell deathWu Li0Wen Lyu1Songjun Liu2Fan Ruan3Xinmei Zhang4Department of Gynecology, Women’s Hospital School of Medicine Zhejiang University, Hangzhou City, ChinaDepartment of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou City, ChinaDepartment of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou City, ChinaDepartment of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou City, ChinaDepartment of Gynecology, Women’s Hospital School of Medicine Zhejiang University, Hangzhou City, ChinaBackground Despite the strong evidence concerning carcinogenic roles of glucagon-like peptide 1 receptor (GLP1R), the role of this gene in endometrial cancer (EC) remains elusive. This study investigated the properties of GLP1R on EC in vitro.Methods The expression of GLP1R in EC was detected by RT-qPCR, immunohistochemistry, and western blotting. Cell viability, cell cycle, apoptosis, migration, invasion and ferroptosis were assessed through CCK-8, flow cytometry, wound healing, transwell, DCFH-DA and western blotting, respectively.Results We found that GLP1R was up-regulated in EC than normal specimens. It had the highest expression in AN3CA cells. Cell viability, migration and invasion were significantly reduced, while cell cycle arrest and apoptosis were induced following GLP1R knockdown. The malignant biological behaviours of AN3CA cells were investigated when treated with exendin-4 (GLP1R agonist). Moreover, GLP1R lowered intracellular ROS level and expression of SLC7A11, and FTH1, but mitigated GPX4 expression in AN3CA cells.Conclusion In a word, GLP1R was up-regulated in EC and its up-regulation facilitated the proliferative and metastatic potentials, and protected cells from ferroptosis, thereby accelerating EC progression. These data emphasised the potency of GLP1R as a therapeutic agent against EC.https://www.tandfonline.com/doi/10.1080/01443615.2023.2301324Endometrial cancerGLP1Rferroptosis |
spellingShingle | Wu Li Wen Lyu Songjun Liu Fan Ruan Xinmei Zhang GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death Journal of Obstetrics and Gynaecology Endometrial cancer GLP1R ferroptosis |
title | GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death |
title_full | GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death |
title_fullStr | GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death |
title_full_unstemmed | GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death |
title_short | GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death |
title_sort | glp1r boosts survival migration and invasion of endometrial cancer cells and protects against ferroptotic cell death |
topic | Endometrial cancer GLP1R ferroptosis |
url | https://www.tandfonline.com/doi/10.1080/01443615.2023.2301324 |
work_keys_str_mv | AT wuli glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath AT wenlyu glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath AT songjunliu glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath AT fanruan glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath AT xinmeizhang glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath |